The pemetrexed/gemcitabine combination in pancreatic cancer (Q34810763)
scientific article
Language:
Current Data About The pemetrexed/gemcitabine combination in pancreatic cancer
(P31) (Q13442814)
(P248)
(P698) 12209673
(P813) Friday, August 4, 2017

(P304) 928-932
(P248)
(P698) 12209673
(P813) Friday, August 4, 2017

(P407) (Q1860)

(P433) 4 Suppl
(P248)
(P698) 12209673
(P813) Friday, August 4, 2017

(P478) 95
(P248)
(P698) 12209673
(P813) Friday, August 4, 2017

(P577) Thursday, August 1, 2002
(P248)
(P698) 12209673
(P813) Friday, August 4, 2017

(P921) (Q212961)
(P887)

(P1433) (Q326041)
(P248)
(P698) 12209673
(P813) Friday, August 4, 2017

(P1476) "The pemetrexed/gemcitabine combination in pancreatic cancer" (language: en)
(P248)
(P698) 12209673
(P813) Friday, August 4, 2017

(P2093) Hedy Lee Kindler
(P1545) 1
(P248)
(P698) 12209673
(P813) Friday, August 4, 2017

(P2860) (Q28189339)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FCNCR.10755
(P813) Sunday, January 21, 2018

(Q34126550)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FCNCR.10755
(P813) Sunday, January 21, 2018

(Q33491184)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FCNCR.10755
(P813) Sunday, January 21, 2018

(Q29547565)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FCNCR.10755
(P813) Sunday, January 21, 2018

(Q41872183)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FCNCR.10755
(P813) Sunday, January 21, 2018

(Q54087864)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FCNCR.10755
(P813) Sunday, January 21, 2018

(Q33330147)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FCNCR.10755
(P813) Sunday, January 21, 2018

(Q33331583)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FCNCR.10755
(P813) Sunday, January 21, 2018

(Q64903661)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FCNCR.10755
(P813) Thursday, January 7, 2021
(P887)

(Q73675198)
(P248)
(P854) https://api.crossref.org/works/10.1002%2FCNCR.10755
(P813) Thursday, January 7, 2021
(P887)

(P13046) (Q7318358)
(P248)

other details